26 January 2022>: Review Paper
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Wojciech Andrzej Straś 1AEF , Dariusz Wasiak 1F , Beata Łągiewska 2F , Olga Tronina 3EF* , Marta Hreńczuk 1F , Joanna Gotlib 4F , Wojciech Lisik 2AF , Piotr Małkowski 1AEFGDOI: 10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
Table 1 Risk factors predicting hepatocellular carcinoma before and after liver transplantation.
Risk factors | Ref. | |
---|---|---|
Risk factors before transplantation | ✓ Numer and size of the nodules | [,,]19 |
✓ Vascular invasion | [,]11 | |
✓ Alpha-Fetoprotein level | [,,]27 | |
✓ Neutrophil-lymphocyte ratio | [,,,–]19 | |
✓ Positron emission tomography scan/magnetic resonance imaging | [,–]19 | |
✓ Bridging therapy response | [,,,–]8 | |
✓ Metabolic syndrome, obesity | [–]54 | |
✓ HBV and HCV viral infections | [–]64 | |
✓ Biopsy | [–]85 | |
✓ Time to transplantation | 17, 88–89 | |
Post-transplantation risk factors | ✓ Degree of tumor differentiation, vascular invasion | [,–]11 |
✓ Liver donor | [–]92 | |
✓ Cold ischemia time | [–]96 | |
✓ Operating technique | [,]99 | |
✓ Immunosuppression | [–]101 | |
✓ Adjuvant treatment | [,–]21 |